Total Payments
$1,938
2024 Payments
$711.77
Companies
34
Transactions
91
Medicare Patients
411
Medicare Billing
$71,890
Payment Breakdown by Category
Food & Beverage$1,843 (95.1%)
Education$95.00 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,843 | 90 | 95.1% |
| Education | $95.00 | 1 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $256.12 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $188.92 | 6 | $0 (2024) |
| Incyte Corporation | $187.17 | 9 | $0 (2024) |
| BeiGene USA, Inc. | $108.08 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $98.52 | 4 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $94.38 | 5 | $0 (2023) |
| ABBVIE INC. | $88.70 | 4 | $0 (2024) |
| Genmab U.S., Inc. | $80.83 | 3 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $78.96 | 3 | $0 (2024) |
| SOBI, INC | $71.08 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $711.77 | 34 | BeiGene USA, Inc. ($73.77) |
| 2023 | $895.33 | 39 | Astellas Pharma US Inc ($155.56) |
| 2022 | $234.90 | 13 | Janssen Biotech, Inc. ($89.40) |
| 2021 | $96.01 | 5 | Janssen Biotech, Inc. ($58.98) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $20.66 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Oncology | ||||||
| 12/11/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Oncology | ||||||
| 12/05/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/12/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 11/07/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Oncology | ||||||
| 10/24/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Oncology | ||||||
| 10/21/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/03/2024 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Oncology | ||||||
| 09/19/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Oncology | ||||||
| 09/09/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/06/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Infectious Diseases | ||||||
| 08/16/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/14/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2024 | BTG International, Inc. | Voraxaze (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 07/03/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/26/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TECVAYLI | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 04/23/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Oncology | ||||||
| 04/18/2024 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 162 | 284 | $141,207 | $27,866 |
| 2022 | 3 | 136 | 214 | $80,608 | $23,300 |
| 2021 | 3 | 113 | 193 | $71,514 | $20,723 |
Total Patients
411
Total Services
691
Medicare Billing
$71,890
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 77 | 154 | $85,731 | $18,160 | 21.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 68 | $27,178 | $5,439 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 21 | $8,765 | $1,772 | 20.2% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 13 | 13 | $7,625 | $1,584 | 20.8% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 15 | 16 | $9,794 | $811.52 | 8.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 11 | 12 | $2,114 | $99.48 | 4.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 82 | 146 | $55,076 | $17,615 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 34 | $9,750 | $2,875 | 29.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2022 | 15 | 17 | $7,839 | $1,977 | 25.2% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 14 | 17 | $7,943 | $833.62 | 10.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 70 | 136 | $52,936 | $16,053 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 44 | $12,558 | $3,977 | 31.7% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 13 | 13 | $6,020 | $693.42 | 11.5% |
About Ryan Nickerson, NP
Ryan Nickerson, NP is a Acute Care healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2020. The National Provider Identifier (NPI) number assigned to this provider is 1578179503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Nickerson, NP has received a total of $1,938 in payments from pharmaceutical and medical device companies, with $711.77 received in 2024. These payments were reported across 91 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($1,843).
As a Medicare-enrolled provider, Nickerson has provided services to 411 Medicare beneficiaries, totaling 691 services with total Medicare billing of $71,890. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Other Specialties Nurse Practitioner
- Location Denver, CO
- Active Since 09/15/2020
- Last Updated 11/29/2022
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1578179503
Products in Payments
- IMBRUVICA (Drug) $160.50
- DARZALEX (Biological) $160.42
- JAKAFI (Drug) $130.23
- BRUKINSA (Drug) $108.08
- Epkinly (Drug) $80.83
- EPKINLY (Drug) $58.82
- BOSULIF (Drug) $57.38
- MONJUVI (Drug) $56.94
- Vanflyta (Drug) $54.76
- RYLAZE (Drug) $53.76
- VONJO (Drug) $51.50
- Xospata (Drug) $49.75
- CARVYKTI (Biological) $46.48
- Cresemba (Drug) $44.17
- VENCLEXTA (Drug) $43.85
- SCEMBLIX (Drug) $42.66
- LIVTENCITY (Drug) $42.45
- SIGNIA (Device) $40.46
- Empaveli (Drug) $40.25
- ICLUSIG (Drug) $30.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Denver
Jennifer Faber Gerling, Np, NP
Acute Care — Payments: $25,384
Acute Care $25,384
Lauren Spitzinger, Np, NP
Acute Care — Payments: $9,693
Acute Care $9,693
Abigail Koehler, Acnpc-Ag, ACNPC-AG
Acute Care — Payments: $3,178
Acute Care $3,178
Emily Zeszutek, Msn, Agacnp-Bc, Ccrn, MSN, AGACNP-BC, CCRN
Acute Care — Payments: $1,877
Acute Care $1,877
Sarah Robbins, Acnp, ACNP
Acute Care — Payments: $1,609
Acute Care $1,609
Whitney Anderson
Acute Care — Payments: $1,178
Acute Care $1,178